IP Library Granted Patent US 10,010,566
Granted Patent B2
US 10,010,566 · App. 14/004,947 · Granted Jul 3, 2018

Compositions and methods useful for ameliorating age related maladies

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,010,566
App. No.
14/004,947
Granted
Jul 3, 2018
Kind
B2
Abstract

The invention provides methods and compositions useful for ameliorating age related maladies, enhancing and maintaining immune function, enhancing and maintaining cognitive function, enhancing and maintaining muscle strength, enhancing and maintaining balance, and reducing and mitigating oxidative stress in an animal. The compositions comprise a combination of at least two of one or more unsaturated fatty acids (UFA); one or more nitric oxide releasing compounds (NORC); one or more anti-glycation agents; and colostrum, and the methods comprise administering to an animal a therapeutically effective amount of the compositions.

Claims (15)

1. A method for ameliorating age related maladies in a healthy animal comprising administering to the animal individually therapeutically effective amounts of:

one or more anti-glycation agents including alpha lipoic acid in an amount from about 1 to 500 mg/kg/day;

one or more UFA including fish oil in an amount from about 0.01 to 500 mg/kg/day;

one or more NORC including citrulline in an amount from about 0.001 to 10 g/kg/day; and

colostrum in an amount from about 0.001 to 10 g/kg/day;

wherein the age related malady is loss of muscle strength or loss of balance.

2. The method of claim 1 wherein the UFA additionally comprises one or more of ALA, EPA, DPA, DHA, or another n-3 fatty acid from any source.

3. The method of claim 1 wherein the NORC additionally comprises arginine or a nitric oxide-releasing derivative thereof.

4. The method of claim 1 wherein the anti-glycation agent additionally comprising a member selected from the group consisting of carnosine, benfotiamine, pyridoxamine, phenacyldimethylthiazolium chloride, taurine, aminoguanidine, resveratrol, and aspirin.

5. The method of claim 1 wherein the fish oil is administered in an amount from about 0.1 to 250 mg/kg/day, citrulline is administered in an amount from about 0.12 to 5 g/kg/day, alpha lipoic acid is administered in an amount from about 10 to 100 mg/kg/day, and colostrum is administered in an amount from about 0.1 to 5 g/kg/day.

6. The method of claim 1 wherein the combination is formulated as a human food composition, pet food composition, or a dietary supplement.

7. The method of claim 1 , wherein the age related malady is a loss of muscle strength.

8. The method of claim 1 , wherein the age related malady is a loss of balance.

9. The method of claim 1 , wherein the animal is a companion animal.

10. The method of claim 1 , wherein the animal is a canine.

Assignments (4)
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0001 →
CORRECTIVE ASSIGNMENT TO CORRECT THE PATENT NUMBER 16062921 PREVIOUSLY RECORDED ON REEL 049391 FRAME 0756. ASSIGNOR(S) HEREBY CONFIRMS THE PATENT NUMBER SHOULD HAVE BEEN 16062912. Recorded Jul 3, 2020
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 054082/0165 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ENGLISH TRANSLATION TO SHOW THE FULL AND CORRECT NEW NAME IN SECTION 51. PREVIOUSLY RECORDED AT REEL: 049391 FRAME: 0756. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Jun 13, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049853/0398 →
MERGER Recorded Jun 6, 2019
From: NESTEC S.A.
To: SOCIÉTÉ DES PRODUITS NESTLÉ S.A.
Reel/Frame 049391/0756 →